Medicare Pressed To Expand Home Infusion Emergency Access Plan Even Further

Plan to allow broader coverage for home infused drugs during the COVID-19 emergency prompts opposition from providers seeking an approach more in line with commercial insurance practices.

Silhouette of a doctor walking in a hurry in the hospital corridor.
Plan Aims To Keep Seniors Out Of The Hospital

The US Centers for Medicare and Medicaid Service’s plan to increase Medicare coverage for home infused drugs during the COVID-19 pandemic is unlikely to provide a meaningful increase in access, according to infusion providers and other health care stakeholders.

The plan is part of an interim final rule released in late March. It would broaden the number of Part...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet